Tirzepatide is a dual GLP-1 / GIP receptor agonist medication that may be considered for certain patients as part of a physician-supervised weight-management plan. A licensed provider determines whether tirzepatide is appropriate based on individual medical history and eligibility. Individual response and outcomes vary.
What your provider may discuss during consultation
- Whether GLP-1 / GIP therapy may align with your individual goals
- Effects on appetite signaling as part of your overall plan
- Glycemic and metabolic considerations relevant to your medical history
- Lifestyle integration, adherence, and follow-up
- Monitoring schedule and laboratory work, as appropriate
Individual response varies. No specific outcome is promised. Not all patients are candidates.
How treatment is initiated
Treatment begins with a one-on-one telemedicine consultation with a licensed provider, who reviews your medical history, screens for contraindications, and determines whether tirzepatide is clinically appropriate for you. Self-administration technique, if applicable, is taught by the provider after they have determined the medication is appropriate.
Frequently asked questions
How is eligibility determined?
A licensed provider determines eligibility after a comprehensive evaluation. Patients with certain conditions — including a personal or family history of medullary thyroid carcinoma, MEN-2, pancreatitis, pregnancy or breastfeeding, among others — are not candidates. Your provider will review contraindications during consultation.
How does tirzepatide work?
Tirzepatide acts on pathways related to appetite signaling and glucose regulation. Mechanism information is for education only and is not a benefit claim. Your provider will explain the mechanism, potential effects, side effects, and alternatives during consultation.
How quickly will I see results?
Individual response varies. Your provider will discuss expectations during consultation. We do not promise specific timelines or outcomes.
How is it stored?
Storage instructions are reviewed by the prescribing provider or pharmacy when your medication is dispensed. The specific form (vial or pen) depends on what is prescribed for you.
Important Information About This Treatment
This medication is available by prescription only. Eligibility, dosing, and continuation are determined by a licensed provider after a clinical consultation. Booking a consultation does not mean this medication will be prescribed for you. Treatment is not appropriate for everyone.
Individual Response. Outcomes vary from patient to patient. We do not promise any specific outcome.
Reporting Adverse Events. If you experience a side effect, contact us, your prescribing provider, and FDA MedWatch at https://www.fda.gov/safety/medwatch.
Emergencies. This site and our telehealth services are not for medical emergencies. Call 911 in a medical emergency.
